Research news
A study following Scottish international rugby players shows they are more likely to develop neurodegenerative conditions compared to the general public.
A project involving Parkinson’s UK, shows promise for using artificial intelligence to identify Parkinson’s in brains donated to our Brain Bank.
Scientists at the University of Manchester have developed a test which could help diagnose Parkinson’s in 3 minutes using a simple skin swab.
The £2.9m phase 2 trial of a drug that could slow the progression of conditions like Parkinson's will be funded by the Parkinson's Virtual Biotech, our international drug discovery and development programme.
2 clinical trials aiming to reduce the clumps of troublesome alpha-synuclein to protect brain cells have, so far, failed to show a clear benefit for people with Parkinson’s.
We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023.
An app that links to Apple Watch technology has been granted FDA approval to help monitor some motor symptoms experienced by people with Parkinson’s.
We’re calling on the Parkinson’s community to take part in 5 important clinical studies that are currently at risk of closure.
We've invested a further £490,000 to support the development of drugs to protect mitochondria and treat Parkinson's.
Parkinson's UK funded research suggests it may be possible to prevent the formation of protein clumps that cause problems in Parkinson's by using microscopic tweezers that pull apart the proteins. This could pave the way for a therapy that could slow or stop the progression of the condition.